Moniret (Dimetindene Maleate)

Dimetindene maleate, the active ingredient in Moniret, is a first‑generation antihistamine presented as a topical formulation for skin application. It is used to relieve itching and inflammation associated with allergic skin reactions, insect bites, and atopic dermatitis in adults and children.

GNH USA supplies Moniret as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory documentation for each batch.

Dimetindene maleate is applied topically to address histamine‑mediated skin conditions.

Allergic skin reactions: reduces redness, swelling and itching caused by contact allergens. Pruritus (itching): provides symptomatic relief of generalized or localized itching. Insect bite reactions: alleviates itching and inflammation from mosquito, flea or other insect bites. Atopic dermatitis: helps control flare‑ups and associated itch in eczema patients. Contact dermatitis: eases symptoms of irritant‑induced dermatitis.

Topical dimetindene may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: mild redness or burning at the application site. - Dryness: localized skin dryness. - Pruritus: paradoxical itching in a small number of users. - Erythema: mild redness surrounding the treated area.

Serious or Rare Side Effects: - Contact dermatitis: allergic reaction to the formulation. - Systemic anticholinergic effects: dry mouth, blurred vision, urinary retention. - Severe hypersensitivity: angioedema or anaphylaxis (rare).

When using Moniret, consider the following precautions to ensure safe and effective therapy.

Age restriction: avoid use in children under 2 years unless advised by a clinician. Pregnancy and lactation: safety not established; use only if benefit outweighs risk. Concurrent eye exposure: prevent contact with eyes to avoid irritation. Skin integrity: do not apply to broken or infected skin. Drug interactions: be aware of additive anticholinergic effects with other antihistamines or anticholinergic agents. Store below 25°C: keep in original container, protect from moisture and light.

Dimetindene may interact with other medicines that influence histamine pathways or possess anticholinergic activity.

Major Interactions (Avoid): - Other first‑generation antihistamines: combined use can increase sedation and anticholinergic burden. - Anticholinergic drugs (e.g., trihexyphenidyl, atropine): may potentiate dry mouth, urinary retention, and blurred vision.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: concurrent use may enhance skin thinning risk. - Alcohol: may increase sedation when systemic absorption occurs. - MAO inhibitors: potential for heightened antihistaminic effects.